- Home
- GRFS vs ITGR Comparison
GRFS vs ITGR Comparison
Compare GRFS & ITGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRFS | ITGR |
|---|---|---|
| Founded | 1940 | 1970 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.3B |
| IPO Year | 2008 | 2000 |
Fundamental Metrics
Financial Performance| Metric | GRFS | ITGR |
|---|---|---|
| Price | $7.53 | $126.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 9 |
| Target Price | $10.87 | ★ $121.80 |
| AVG Volume (30 Days) | 445.0K | ★ 662.2K |
| Earning Date | 07-28-2022 | 10-22-2026 |
| Dividend Yield | ★ 1.14% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.17 |
| Revenue | N/A | ★ $1,853,637,000.00 |
| Revenue This Year | $1.73 | N/A |
| Revenue Next Year | $6.26 | $5.96 |
| P/E Ratio | ★ $18.67 | $108.12 |
| Revenue Growth | N/A | ★ 7.98 |
| 52 Week Low | $6.96 | $62.00 |
| 52 Week High | $9.90 | $126.80 |
Technical Indicators
Market Signals| Indicator | GRFS | ITGR |
|---|---|---|
| Relative Strength Index (RSI) | 51.65 | 74.67 |
| Support Level | $7.44 | $126.16 |
| Resistance Level | $7.73 | $126.54 |
| Average True Range (ATR) | 0.12 | 0.18 |
| MACD | 0.02 | -0.38 |
| Stochastic Oscillator | 91.57 | 75.45 |
Price Performance
Historical ComparisonAbout GRFS Grifols S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
About ITGR Integer Holdings Corporation
Integer Holdings Corp is a manufacturer of medical device components used by original equipment manufacturers in the medical industry. The firm organizes itself into one segment and derives its revenues from three product lines: Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation and Other Markets. The company earns maximum of its revenue in the United States, and also has its presence in Ireland, Puerto Rico, Costa Rica, and Rest of the World.